cytarabine has been researched along with Leukemia, Megakaryocytic in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (9.43) | 18.7374 |
1990's | 20 (37.74) | 18.2507 |
2000's | 19 (35.85) | 29.6817 |
2010's | 9 (16.98) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakare, BY; Bello, FO; Ojo, OT; Olatunji, AO; Olatunji, PO | 1 |
Abla, O; Adachi, S; Auvrignon, A; Beverloo, HB; Chang, TT; Creutzig, U; de Bont, E; De Moerloose, B; Dworzak, M; Elitzur, S; Forestier, E; Fynn, A; Hasle, H; Inaba, H; Lee, V; Liang, DC; Locatelli, F; Masetti, R; Raimondi, SC; Reinhardt, D; Rodriguez, L; Shen, S; Taga, T; Tomizawa, D; Van Roy, N; Yeoh, AE; Zhou, Y; Zimmermann, M | 1 |
Boerner, JL; Buck, SA; Dombkowski, AA; Edwards, H; Ge, Y; LaFiura, KM; Matherly, LH; Taub, JW; Xie, C | 1 |
Bessho, F; Hama, A; Ishii, R; Kinoshita, A; Kobayashi, N; Kojima, S; Kudo, K; Morimoto, A; Okimoto, Y; Sunami, S; Tawa, A; Tsukimoto, I | 1 |
Alonzo, TA; Arceci, RJ; Barnard, D; Doyle, J; Gamis, AS; Gerbing, RB; Hilden, JM; Loew, TW; Massey, G; Perentesis, J; Ravindranath, Y; Sharma, M; Smith, FO; Sorrell, AD; Taub, J | 1 |
Balci, TB; Berman, JN; Buck, SA; Dellaire, G; Dombkowski, AA; Edwards, H; Ge, Y; Matherly, LH; Taub, JW; Xavier, AC; Xie, C | 1 |
Roberts, I; Vyas, P | 1 |
Kimoto, Y; Moritake, H; Nunoi, H; Sawa, D; Shimonodan, H; Yamada, A | 1 |
Creutzig, U; Klusmann, JH; Kolenova, A; Neuhoff, C; Pekrun, A; Reinhardt, D; Reinhardt, K; Rössig, C; Sander, A; Sauerbrey, A; von Stackelberg, A | 1 |
Bacher, U; Bokemeyer, C; Fiedler, W; Haalck, T; Janjetovic, S; Janning, M | 1 |
Ge, Y; Jensen, TL; Matherly, LH; Taub, JW | 1 |
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
Cetin, M; Erdemli, E; Gürgey, A; Hiçsönmez, G; Okur, H | 1 |
Fouillard, L; Frassoni, F; Gorin, NC; Labopin, M; Meloni, G; Polge, E | 1 |
Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G | 1 |
Buck, S; Ge, Y; Jensen, TL; Matherly, LH; Ravindranath, Y; Stout, ML; Tatman, DA; Taub, JW; Thomas, RL | 1 |
Bradbury, J | 1 |
Creutzig, U; Diekamp, S; Dworzak, M; Fleischhack, G; Harbott, J; Langebrake, C; Ludwig, WD; Reinhardt, D; Ritter, J; Schrauder, A; Stary, J; Zimmermann, M | 1 |
Creutzig, U; Diekamp, S; Dworzak, M; Reinhardt, D; Stary, J; Zimmermann, M | 1 |
Becton, DL; Buck, SA; Dombkowski, AA; Ge, Y; LaFiura, KM; Massey, G; Matherly, LH; Ravindranath, Y; Stout, ML; Tatman, D; Taub, JW; Weinstein, HJ; Yedidi, RS | 1 |
Al-Ahmari, A; Hitzler, J; Shah, N; Sung, L; Zipursky, A | 1 |
Becton, DL; Buck, S; Chang, M; Raimondi, SC; Ravindranath, Y; Savaşan, S; Weinstein, H | 1 |
Hamamoto, K; Hanada, R; Horibe, K; Imaizumi, M; Kigasawa, H; Kobayashi, R; Kojima, S; Kudo, K; Morimoto, A; Nakayama, H; Tabuchi, K; Tawa, A; Tsuchida, M; Tsukimoto, I; Yabe, H | 1 |
Buck, SA; Chen, Q; Diakiw, AE; Dombkowski, AA; Ge, Y; LaFiura, KM; Matherly, LH; Payton, SG; Salagrama, S; Taub, JW | 1 |
Hirabayashi, N; Kitoh, J; Morishima, Y; Ogura, M; Okumura, M; Saito, H; Takeo, T | 1 |
Grønn, M; Holte, H; Lie, SO; Seip, M; Slørdahl, SH; Smeland, EB | 1 |
Bernaudin, F; Boccara, JF; Denavit, MF; Dommergues, JP; Lejeune, F; Tchernia, G | 1 |
Buck, SA; Gurney, JG; Matherly, LH; Ravindranath, Y; Stout, ML; Taub, JW | 1 |
Mark, HF; Medeiros, LJ; Miranda, RN; Rintels, P; Wu, CD | 1 |
Ishikawa, J; Kanakura, Y; Kato, T; Matsumura, I; Matsuzawa, Y; Miyagawa, J; Miyazaki, H; Nakajima, K; Oritani, K; Tomiyama, Y | 1 |
Arthur, DC; Bloomfield, CD; Heinonen, K; Lawrence, D; MacCallum, J; Mrózek, K; Pettenati, MJ; Qumsiyeh, MB; Schiffer, CA; Stamberg, J; Verma, RS | 1 |
Armesto, A; Bello, JA; del Río, D; García Torremocha, S; Rodríguez, M; Sastre, JL; Ulibarrena, C; Vázquez, O | 1 |
Hidaka, E; Ito, S; Koike, K; Koike, T; Komiyama, A; Kurokawa, Y; Matsuura, H; Miki, J; Nakazawa, T; Sakashita, K; Sawai, N | 1 |
Akiyama, Y; Eguchi, M; Hayashi, Y; Hosoi, G; Ishii, E; Kato, K; Koike, K; Kojima, S; Nishimura, S; Ohara, A; Okamura, J; Okimoto, Y; Sako, M; Sato, T; Tsukimoto, I; Ueda, K; Yazaki, M; Yoshikawa, T | 1 |
Bennett, JM; Cassileth, PA; Dewald, G; Francois, CJ; Neuberg, D; Oken, MM; Paietta, E; Rowe, JM; Tallman, MS; Wiernik, PH | 1 |
Druker, BJ; Kolibaba, KS; Ohno-Jones, S; Thiesing, JT | 1 |
Behm, FG; Pritchard, M; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Srivastava, DK; Tong, X | 1 |
Miyauchi, J; Okui, M; Sugita, K; Taguchi, N | 1 |
Ijima, H; Kuroume, T; Nakazawa, S; Oshima, Y; Shitara, T; Sotomatu, M; Suetake, N; Yugami, S | 1 |
Caballero, MD; Gómez-Almaguer, D; González, M; Lobato-Mendizábal, E; Orfao, A; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ; Ruiz-Reyes, G; San-Miguel, JF; Vidriales, B | 1 |
DeNicola, DB; Hamilton, TA; Morrison, WB | 1 |
Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Saito, H; Tsushita, K | 1 |
Dommergues, JP; Garel, D; Gaulard, P; Mielot, F; Quillard, J; Tchernia, G | 1 |
Granada, I; Las Heras, G; Millá, F; Ribera, JM | 1 |
Farhi, DC; Rosenthal, NS | 1 |
García Díez, I; Palomera Bernal, L | 1 |
Donhuijsen-Ant, R; Leder, LD; Löffler, H; Schadeck-Gressel, C; Schmidt, U; Westerhausen, M | 1 |
Kühn, B; Löffler, H; Polchau, H; Rister, M; Suttorp, M | 1 |
Arlin, ZA; Feldman, EJ; Puccio, CA | 1 |
Brecher, ML; Freeman, AI; Green, DM; Sandberg, AA; Simon, JH; Tebbi, CK | 1 |
Marín-López, A; Pérez-Romano, B; Ruiz-Argüelles, GJ; Ruiz-González, DS | 1 |
García Díez, I; Palomera, L; Torres, A; Velasco, F; Woessner, S | 1 |
Allsbrook, WC; Beck, J; Brubaker, LH; Martinez, J; Melhus, O; Pantazis, CG | 1 |
3 review(s) available for cytarabine and Leukemia, Megakaryocytic
Article | Year |
---|---|
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction | 2004 |
Acute megakaryoblastic leukemia: a case report.
Topics: Acid Phosphatase; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Neoplasm Proteins; Neoplastic Stem Cells; Primary Myelofibrosis | 1990 |
Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Clone Cells; Cyclophosphamide; Cytarabine; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Megakaryoblastic, Acute; Methotrexate; Mosaicism; Prednisone; Thioguanine; Trisomy | 1987 |
5 trial(s) available for cytarabine and Leukemia, Megakaryocytic
Article | Year |
---|---|
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Cytarabine; Disease Progression; Down Syndrome; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Myeloproliferative Disorders; Prognosis; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Survival Rate; Treatment Outcome | 2005 |
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Prospective Studies; Treatment Outcome | 2007 |
An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Probability; Remission Induction; Survival Rate; Time Factors; Treatment Outcome | 2000 |
Long-term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Thrombocythemia, Essential | 1992 |
45 other study(ies) available for cytarabine and Leukemia, Megakaryocytic
Article | Year |
---|---|
A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Topics: Anemia; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Daunorubicin; Fatigue; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Lost to Follow-Up; Muscle Weakness; Thrombocytopenia; Young Adult | 2018 |
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Chromosome Aberrations; Cytarabine; Disease-Free Survival; Female; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Prognosis; Retrospective Studies; Treatment Outcome | 2015 |
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.
Topics: Child; Class I Phosphatidylinositol 3-Kinases; Core Binding Factor Alpha 2 Subunit; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia, Megakaryoblastic, Acute; Oligonucleotide Array Sequence Analysis; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured | 2009 |
Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
Topics: Antimetabolites, Antineoplastic; Child, Preschool; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Down Syndrome; Female; GATA1 Transcription Factor; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Mosaicism; Prevalence; Retrospective Studies; Survival Rate | 2010 |
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Daunorubicin; Down Syndrome; Down-Regulation; Etoposide; GATA1 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Interleukin-1alpha; Lentivirus; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering | 2011 |
Enigmatic variation.
Topics: Cytarabine; Down Syndrome; Female; Humans; Leukemia, Megakaryoblastic, Acute; Male; Myeloproliferative Disorders | 2011 |
Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.
Topics: Antimetabolites, Antineoplastic; Biomarkers; Biomarkers, Tumor; Cytarabine; Cytokines; Disease Progression; Down Syndrome; Drug Monitoring; Female; GATA1 Transcription Factor; Genetic Predisposition to Disease; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukemia, Megakaryoblastic, Acute; Mucin-1; Myeloproliferative Disorders; Neoplasm Proteins; Prednisone; Pulmonary Fibrosis; Remission Induction | 2012 |
[GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Down Syndrome; Female; Follow-Up Studies; GATA1 Transcription Factor; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Mosaicism; Mutation; Myelopoiesis; Myeloproliferative Disorders | 2012 |
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.
Topics: Adult; Aneuploidy; Cytarabine; Daunorubicin; DNA Repair; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Neoadjuvant Therapy; Recurrence; Remission Induction; Transplantation, Homologous; Vidarabine; Xeroderma Pigmentosum | 2013 |
Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines.
Topics: Cystathionine beta-Synthase; Cytarabine; DNA; DNA-Binding Proteins; Down Syndrome; Gene Expression Regulation, Enzymologic; Humans; Leukemia, Megakaryoblastic, Acute; Luciferases; Mutagenesis, Site-Directed; Phosphorylation; Promoter Regions, Genetic; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2003 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Child, Preschool; Cytarabine; Flow Cytometry; Humans; Leukemia, Megakaryoblastic, Acute; Male; Methylprednisolone; Mitoxantrone; Time Factors; Treatment Outcome | 2003 |
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Blotting, Western; Child; Cytarabine; Cytidine Deaminase; DNA-Binding Proteins; Down Syndrome; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Humans; Leukemia, Megakaryoblastic, Acute; Polymerase Chain Reaction; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Up-Regulation | 2005 |
High leukaemia cure rate in Down's syndrome explained.
Topics: Cytarabine; DNA-Binding Proteins; Down Syndrome; Erythroid-Specific DNA-Binding Factors; Humans; Leukemia, Megakaryoblastic, Acute; Mutation; Transcription Factors | 2005 |
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Male; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
Topics: Child; Cluster Analysis; Cytarabine; DNA Primers; Down Syndrome; GATA1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Megakaryoblastic, Acute; Luciferases; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured | 2006 |
Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Diterpenes; Down Syndrome; Drug Administration Schedule; Epidemiologic Methods; Humans; Leukemia, Megakaryoblastic, Acute; Retinyl Esters; Treatment Outcome; Vincristine; Vitamin A | 2006 |
CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Topics: Adolescent; Adult; Biomarkers, Tumor; CD36 Antigens; Cell Membrane; Child; Child, Preschool; Cytarabine; Daunorubicin; Down Syndrome; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Sensitivity and Specificity; Treatment Outcome | 2006 |
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
Topics: Acute Disease; Cell Differentiation; Child; Chromosomes, Human, Pair 21; Cytarabine; Daunorubicin; Down Syndrome; Drug Resistance, Neoplasm; Erythroid Precursor Cells; Erythropoiesis; GATA1 Transcription Factor; Gene Dosage; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Humans; K562 Cells; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Neoplasm Proteins; Proto-Oncogene Mas; Proto-Oncogene Protein c-ets-2; Thrombopoiesis | 2008 |
New xenografts of human megakaryoblastic cell line (MEG-01) for evaluating anti-tumor agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Screening Assays, Antitumor; Humans; Leukemia, Megakaryoblastic, Acute; Male; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine | 1993 |
Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Biomarkers, Tumor; Cytarabine; Down Syndrome; Doxorubicin; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Male; Microscopy, Fluorescence; Neoplastic Stem Cells | 1993 |
Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
Topics: Antimetabolites, Antineoplastic; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Drug Administration Schedule; Female; Humans; Infant; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Male; Remission Induction | 1996 |
Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Line, Transformed; Cells, Cultured; Child; Child, Preschool; Chromosomes, Human, Pair 21; Cystathionine beta-Synthase; Cytarabine; Deoxycytosine Nucleotides; Disease-Free Survival; Down Syndrome; Female; Herpesvirus 4, Human; Homocysteine; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Methotrexate; Myelodysplastic Syndromes; Neoplastic Stem Cells; Remission, Spontaneous; Survival Rate | 1996 |
Chronic myeloid leukemia manifested during megakaryoblastic crisis.
Topics: Adult; Antimetabolites, Antineoplastic; Blast Crisis; Bone Marrow; Bone Marrow Transplantation; Cytarabine; Fatal Outcome; Humans; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 1996 |
Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
Topics: Antimetabolites, Antineoplastic; Carrier Proteins; Cell Cycle Proteins; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p18; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; DNA-Binding Proteins; Enzyme Inhibitors; Genes, Tumor Suppressor; Humans; Leukemia, Megakaryoblastic, Acute; Microtubule-Associated Proteins; Milk Proteins; Protein Kinase Inhibitors; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetradecanoylphorbol Acetate; Thrombopoietin; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chromosomes, Human, Pair 11; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Treatment Outcome; Trisomy | 1998 |
[Testicular granulocytic sarcoma as a form of relapse in a patient with acute megakaryoblastic leukemia].
Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Fatal Outcome; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Megakaryoblastic, Acute; Male; Recurrence; Testicular Neoplasms | 1998 |
[The value of intracellular CD41 antigen detection to the diagnosis of acute megakaryoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Megakaryocytes; Mitoxantrone; Platelet Glycoprotein GPIIb-IIIa Complex; Remission Induction | 1999 |
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antigens; Antigens, CD7; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; CD2 Antigens; Chromosome Aberrations; Chromosomes, Human, Pair 3; Cytarabine; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Peroxidase; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Survival Rate | 2000 |
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells.
Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Cell Division; Cell Survival; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyurea; Imatinib Mesylate; Interleukin-3; Leukemia, Megakaryoblastic, Acute; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Pyrimidines; Stem Cell Factor; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience.
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Inversion; Chromosomes, Human, Pair 16; Cladribine; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Prognosis; Treatment Outcome | 2001 |
[Induction of complete remission in a case of drug-resistant childhood acute megakaryoblastic leukemia by combination of G-CSF and chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Doxorubicin; Drug Resistance; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Megakaryoblastic, Acute; Mercaptopurine; Prednisolone; Remission Induction | 1992 |
A case of congenital leukemia with monosomy 7.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 7; Cytarabine; Doxorubicin; Humans; Infant, Newborn; Karyotyping; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Megakaryoblastic, Acute; Male; Mercaptopurine; Monosomy; Prednisolone; Remission Induction | 1992 |
Cytosine arabinoside chemotherapy for acute megakaryocytic leukemia in a cat.
Topics: Animals; Biopsy; Bone Marrow; Cat Diseases; Cats; Cytarabine; Leukemia, Megakaryoblastic, Acute; Male | 1991 |
[Myelodysplasia predominantly involving in megakaryocytic lineage successfully treated with low-dose Ara-C].
Topics: Adolescent; Cytarabine; Drug Administration Schedule; Humans; Leukemia, Megakaryoblastic, Acute; Male; Myelodysplastic Syndromes; Primary Myelofibrosis | 1991 |
Acute megakaryocytic leukemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment.
Topics: Biopsy; Cytarabine; Follow-Up Studies; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Liver; Male; Primary Myelofibrosis; Remission Induction | 1991 |
[Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 5; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Mitoxantrone; Mosaicism; Remission Induction | 1991 |
Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Topics: Acute Disease; Antigens, CD; Bone Marrow; Cytarabine; Daunorubicin; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Hyperplasia; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Mitoxantrone; Myelodysplastic Syndromes; Prognosis; Time Factors | 1991 |
[Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
Topics: Acute Disease; Aged; beta-Thromboglobulin; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Megakaryoblastic, Acute; Platelet Factor 4; Primary Myelofibrosis; Time Factors | 1990 |
Acute megakaryoblastic leukemia (FAB-M7) in an infant presenting with orbital chloroma and meningeal involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Exophthalmos; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Meningeal Neoplasms; Mitoxantrone; Orbital Neoplasms; Prednisone; Thioguanine; Vincristine | 1990 |
Amsacrine is safe in patients with ventricular ectopy.
Topics: Aged; Amsacrine; Cardiac Complexes, Premature; Cytarabine; Drug Therapy, Combination; Electrocardiography; Heart Ventricles; Humans; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Middle Aged | 1988 |
A prospective trial of the treatment of acute megakaryoblastic leukaemia.
Topics: Adolescent; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Phenotype; Prednisone; Prospective Studies; Remission Induction; Vincristine | 1988 |
[Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
Topics: Aged; Calcitriol; Cytarabine; Female; Humans; Leukemia, Megakaryoblastic, Acute; Primary Myelofibrosis; Remission Induction | 1988 |
Flow cytometry shows recurrent aneuploid clone after remission in megakaryocytic leukemia.
Topics: Aged; Aneuploidy; Biopsy, Needle; Bone Marrow; Cloning, Molecular; Cytarabine; Female; Flow Cytometry; Humans; Leukemia, Megakaryoblastic, Acute | 1988 |